Axsome Therapeutics, Inc.
(NASDAQ : AXSM)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc. -8.31%25.7214.1%$151.34m
AMRNAmarin Corp. Plc -0.99%18.011.7%$106.30m
RVMDRevolution Medicines, Inc. 6.09%30.820.0%$94.96m
CTLTCatalent, Inc. 0.52%59.612.2%$71.76m
GWPHGW Pharmaceuticals Plc 0.85%125.216.2%$63.07m
JAZZJazz Pharmaceuticals Plc 0.89%138.052.3%$56.85m
AXSMAxsome Therapeutics, Inc. -1.06%91.101.9%$56.31m
UTHRUnited Therapeutics Corp. 0.93%106.9714.3%$48.21m
HZNPHorizon Therapeutics Plc 0.90%36.016.6%$46.23m
ICPTIntercept Pharmaceuticals, Inc. -0.97%95.9416.9%$45.02m
SAGESAGE Therapeutics, Inc. -0.71%68.128.6%$44.32m
PRGOPerrigo Co. Plc 0.22%59.086.8%$43.99m
ZGNXZogenix, Inc. 0.39%30.119.4%$42.91m
ENDPEndo International Plc 3.36%6.158.8%$37.18m
MNKMallinckrodt Plc 3.78%4.8120.9%$36.74m

Company Profile

Axsome Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies for the management of central nervous system disorders. Its product candidates include AXS-02 and AXS-06 which are developing for multiple indications. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.